We previously cloned a 19.4-kb DNA region containing a cluster of genes affecting type 1 capsule production from Staphylococcus aureus M. Subcloning experiments showed that these capsule (cap) genes are localized in a 14.6-kb region. Sequencing analysis of the 14.6-kb fragment revealed 13 open reading frames (ORFs). Using
complementation tests, we have mapped a collection of Cap-mutations in 10 of the 13 ORFs, indicating that these 10 genes are involved in capsule biosynthesis. The requirement for the remaining three ORFs in the synthesis of the capsule was demonstrated by constructing site-specific mutations corresponding to each of the three ORFs. Using an Escherichia coli S30 in vitro transcription-translation system, we clearly identified 7 of the 13 proteins predicted from the ORFs. Homology search between the predicted proteins and those in the data bank showed very high homology (52.3% identity) between capL and vipA, moderate homology (29% identity) between capI and vipB, and limited homology (21.8% identity) between capM and vipC. The vipA, vipB, and vipC genes have been shown to be involved in the biosynthesis of SalmoneUla typhi Vi antigen, a homopolymer polysaccharide consisting of N-acetylgalactosamino uronic acid, which is also one of the components of the staphylococcal type 1 capsule. The homology between these sets of genes therefore suggests that capL, capI, and capM may be involved in the biosynthesis of amino sugar, N-acetylgalactosamino uronic acid. In addition, the search showed that CapG aligned well with the consensus sequence of a family of acetyltransferases from various prokaryotic organisms, suggesting that CapG may be an acetyltransferase. Using the isogenic Cap-and Cap' strains constructed in this study, we have confirmed that type 1 capsule is an important virulence factor in a mouse lethality test.
Most strains of Staphylococcus aureus produce capsular polysaccharides. To date, 11 distinct serotypes have been reported (19, 44) . Type 1 or 2 capsule-producing strains produce a large amount of capsule. As a result, these strains are mucoid, phage nontypeable, and clumping factor negative and exhibit a halo around the cells under negative staining with India ink. Although these strains are antiphagocytic and virulent to mice (27, 31, 36) , they are rarely encountered clinically. On the other hand, type 5 and 8 strains are the predominant isolates, which account for about 80% in recent isolates from all sources (2, 4, 14, 17, 19, 37, 44) . These strains, which are referred to as microencapsulated (50) , produce a small amount of capsule and do not possess the characteristics typically associated with type 1 or 2 strains. Microencapsulated type 5 and 8 strains have been shown to be antiphagocytic (18) ; however, this result was not supported by recent studies (1, 5, 52) .
S. aureus M is a type 1 capsule producer isolated from an infected human hand laceration (41) . Since the report of its isolation, strain M has been subjected to intensive study as a prototype of encapsulated staphylococci (see reference 50 for a review). The capsule of strain M is composed of taurine, 2-acetamido-2-deoxy-fucose, and 2-acetamido-2-deoxy-D-galacturonic acid in a molar ratio of 1:2:4 (29, 34) . The presence of taurine in the capsule is dependent on the presence of taurine in the growth medium (51) . The production of capsule in strain M has been correlated with its virulence properties in both the in vitro phagocytic assay and the in vivo mouse lethality assay (31, 36) . It has been shown that the mechanism of resistance to opsonization is due to the masking of the bacterial surface-bound C3b complement by capsule, thus preventing interaction with the receptors on phagocytic cells by the capsule. Antibodies against the capsule were shown to promote opsonization of encapsulated organisms by depositing complement throughout the capsule and the bacterial surface (47) .
To study the molecular biology of capsule biosynthesis in S. aureus, our laboratory previously cloned a region of DNA containing a cluster of capsule (cap) genes from the chromosome of strain M (24) . In this communication, we report the complete nucleotide sequence of the 14.6-kb DNA region containing the cap genes and the characterization of these genes.
MATERIALS AND METHODS
Strains, plasmids, and growth conditions. The bacterial strains and plasmids are listed in Table 1 . Trypticase soy broth or agar (Difco Laboratories, Detroit, Mich.) was used for routine cultivation of S. aureus strains. L broth or agar (Difco) was used for cultivation of Escherichia coli. S. aureus M has been described previously (24) . S. aureus RN4220, a restriction-deficient strain derived from strain 8325-4 (22) , was used as the recipient in electroporation. S. aureus CYL316 was used as the recipient for the single-copy integration vector pCL83 or pCL84 (25) . E. coli LE392 or HB101 was used for plasmid transformations and preparation of plasmids. Electroporation M  CYL5022  CYL5024  CYL5091  CYL5168  CYL5176  CYL5187  CYL5203  CYL5204  CYL5206  CYL5210  CYL5211  CYL5212  CYL5213  CYL5214  CYL5240  CYL5241  CYL5242  CYL5243  CYL5244  CYL5245  CYL5246  CYL5248  CYL5327  CYL5330  CYL5346  CYL5419  CYL5529  CYL5531 (24) . The transduction procedure was carried out described (42) . N-Methyl-N'-nitro-N-nitrosoguanid Sigma Chemical Co., St. Louis, Mo.) was used for as described previously (32) . Cap-mutants wer( screening nonmucoid colonies and were confirme4 staining with India ink as previously described ( vector pCL8 was essentially the same as pLI50, ex ampicillin resistance gene and the multiple cloni derived from pWSK30 (48) . Plasmid pCL52.1 was by cloning the 1.4-kb fragment containing the t sensitive origin of replication of pE194ts into the pCL72 (25) (39) . Plasmid DNA purification was performed by the procedure of Birnboim (7)  22 and further purified by CsCl-ethidium bromide density gradi-251 ent centrifugation or by using the Qiagen plasmid kit (Qiagen,   24 Inc., Chatsworth, Calif.). Rapid small-scale plasmid DNA 24 purification was done by the method of Holmes and Quigley This study (15) . Bulk chromosomal DNA from S. aureus was purified by 24 the method of Dyer and Iandolo (9) . The transfer of DNA to 24 nitrocellulose membranes was by the method of Southern (45) . 24 The conditions used for hybridization analysis have been 24 described previously (26 To construct strain CYL5419, the 7.9-kb insert of the plasmid pCL7325 described above ( Fig. 1) showed that 20 of the 22 mutants were complemented by plasmid clones containing DNA derived from a 19.4-kb DNA region of the S. aureus M chromosome. This result suggests that the majority of the cap genes affecting capsule production in S. aureus M are clustered in the 19.4-kb DNA region of the chromosome (24) . To define the smallest DNA region that still contained this cluster of genes, we performed complementation tests with plasmid subclones derived from a 20-kb DNA fragment containing the original 19.4-kb fragment. We found that all of the mutants previously complemented by the 19.4-kb fragment were complemented by plasmid subclones derived from a shorter DNA fragment 14.6 kb in size. Plasmids containing inserts with additional deletions of 0.6 and 1.8 kb from the left and right ends of the 14.6-kb fragment, respectively, were unable to complement some of the mutants. This result indicates that the minimum size of the DNA region containing this cluster of cap genes is about 14.6 kb.
The nucleotide sequence of the 14.6-kb cap region was then determined as described in Materials and Methods. As shown in Fig. 2 (Fig. 2) .
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Because the EcoRI site (6.2-kb coordinate) that divides the insert fragments cloned in pCL7183 and pWL7327 is located in ORF capF, it is possible that the mutations of the two previously isolated mutants, 5025 and 5027 (24) , which were not complemented by either pCL7183 or pWL7327, mapped in capF. To test this possibility, the 6.2-kb PstI-KpnI (3.5-to 9.7-kb coordinates) fragment in the middle portion of the 14.6-kb fragment was cloned into a plasmid vector. The resultant plasmid, pCL7164, which contains five intact ORFs, capE to capI, was able to complement mutations mapped in capE, capG, and capH as expected but was not able to complement mutant 5025 or mutant 5027.
The complementation results presented above showed that 9 of the 13 ORFs were represented by at least one mutant, whereas no mutation was mapped in capC, capF, capI, or capM. To search for additional mutants that may have mutations mapped in these ORFs, we screened 25 additional mutants generated by MNNG mutagenesis. We found one mutant, 5091, complemented by pCL7164 but not by pCL7183 or pWL7327 (Fig. 3) , indicating that the mutation in 5091 mapped in capF. Most of the other MNNG-induced mutations mapped in capE, and no additional mutation was mapped in capC, capI, or capM.
Mutagenesis. Because no mutation was mapped in the ORFs capC, capI, and capM, we were unable to conclude that these ORFs are involved in capsule biosynthesis. Therefore, we attempted to construct mutants with chromosomal mutations mapped in these three ORFs to determine whether they are involved in biosynthesis of type 1 capsule. Strains CYL5542 and CYL5531, which have mutations corresponding to capI and capM, respectively were constructed as described in Materials and Methods. These site-specific mutants were all Cap-, indicating that both ORF capI and capM are involved in the synthesis of capsule. To confirm that the mutations in strains CYL5542 and CYL5531 are indeed located in ORFs capI and capM, respectively, and to show that the mutation in capI is not polar, we performed complementation tests with the plasmids described in Fig. 3 . The results showed that strain CYL5542 was complemented by pCL7191, which contains intact capG through capI but not by pWL7316 in which most of the ORF capI was deleted, whereas strain CYL5531 was complemented by pWL7327 containing capH through capM but not by pCL7134 containing intact capH through capL. These results indicate that the mutation sites of these sitespecific mutants are mapped at the expected genes and that the mutation in capI is not polar.
The same strategy used to construct the site-specific mutations in capI and capM was used to construct the mutation in capC. However, we were unable to obtain the desired mutation in capC despite several independent attempts. To determine if ORF capC is involved in capsule biosynthesis, we sought a different approach. We constructed a deletion mutation of strain M, CYL5529, in which the DNA fragment between the HindIII site (2.3-kb coordinate within capC) and 1.8 kb upstream of the BglII site (at the 0-kb coordinate) of the genome was deleted and replaced with a 1.7-kb DNA fragment containing the cat gene of pC194 by allelic replacement (see Materials and Methods). Thus, strain CYL5529 is a null mutant with deletion of ORFs capA and capB and most of capC. We then constructed plasmid pCL7398 containing intact capA, capB, and capD and a BamHI linker insertion at the FspI site (2.0-kb coordinate) within ORF capC by using the singlecopy integration vector pCL84, as described in Materials and Methods. The plasmid pCL7398 was then transferred to CYL5529. The resultant strain, CYL5529(pCL7398), which is genotypically equivalent to the wild-type strain M with a capC mutation, was Cap-, implying that ORF capC is involved in capsule biosynthesis. However, it is possible that CYL5529 could have a mutation at other cap genes, which would give rise to the Cap-phenotype regardless of whether capC is essential VOL. 176 , 1994   12244  99  12346  133  12448  167  12550  201  12652  235  127 54  269  12856  303  12958  337  13060  371  13162 (Fig. 3) , it is possible that the mutation at capA affects the expression of the downstream capD gene. To test this possibility, the plasmid pCL7398 was transferred into strain CYL5246 (a capD mutant). The resultant strain was Cap', indicating that the mutation in pCL7398 is not polar.
It is also possible that during in vitro construction of pCL7398, a mutation could be introduced into capA or capB that could also result in the Cap-phenotype seen in CYL5529 (pCL7398). This concern was ruled out in experiments in which we showed that pCL7398 complemented both 5213 (a capA mutant) and 5346 (a capB mutant).
Analysis of gene products. (11) , and AlgD is GDP-mannose dehydrogenase, which catalyzes oxidation of GDP-mannose to GDPmannuronic acid required for alginate biosynthesis by mucoid Pseudomonas aeruginosa (38) . A high degree of homology was also found between the CapI protein and an unidentified reading frame (ORF2) adjacent to the chain-length determinant, which confers a modal distribution of chain length on the 0 antigen component of lipopolysaccharide (LPS) of E. coli (6) . [3] ). The alignment of Tn2424Cat, NodL, LacA, and CysE is taken from Parent (24) . Recognizing this fact, we deliberately cloned the DNA fragment for replacement without the promoter upstream of the capA, yet this approach continued to fail, indicating that there may be a weak promoter from the multiple-copy vector that allows enough gene expression.
To circumvent this problem, we employed a different approach and constructed a null mutant, CYL5529, which produced no capA, capB, capC, or capD; yet expression of other cap genes was not affected. We then constructed plasmid pCL7398 by cloning a DNA fragment containing capA to capE genes with a nonpolar mutation in capC. This plasmid was constructed with a single-copy plasmid vector that integrates at the geh locus of the staphylococcal chromosome (26) to avoid the high-gene-dosage effect of multiple-copy vectors. Because deletion in CYL5529 did not affect the expression of other capsule genes, transferring the pCL7398 into CYL5529 generated a strain equivalent to the M strain with a specific mutation at capC. By using such an approach, we have shown that ORF capC is involved in capsule production.
In the in vitro transcription-translation system, we were able to clearly identify protein bands corresponding to seven predicted ORFs (capA to -E and capJ to -K; Fig. 4 ). This result lends additional support to the argument that these predicted ORFs are likely to be the functional genes. The reason that protein bands corresponding to other ORFs were not detected could be due to the fact that these gene products were not efficiently expressed in the E. coli system or, alternatively, it could be due to the fact that the bands were not resolved in the electrophoretic system we employed. It is interesting that CapE was readily detected, although weakly expressed in pCL7152, but no protein band corresponding to CapE was detected when pCL7164 was expressed, even though our genetic data suggested that CapE was expressed from pCL7164. This discrepancy could be due to the fact that the promoter further upstream of capE, which is not present in pCL7164, may be required for full expression of CapE in E. coli, whereas in S. aureus, CapE may be readily expressed from its own promoter.
The genetic complementation data suggest that the cap genes are organized into at least two operonic structures: one operon consists of capA through capD, with a likely transcription start upstream of capA; the other consists of at least capJ, capK, and capL but may also include capG, capH, capI, and capM, with possible transcription initiated from upstream of capG. In addition, the data also indicate that there is another transcription start upstream of capE. Indeed, by using the Genetics Computer Group program, we have found a potential promoter with close homology to the consensus promoter sequences found in E. coli and Bacillus spp. just upstream of capA (Fig. 2) . Potential promoter sequences were also found upstream of capE and capG, although they were less homologous to the canonical sequences. Although these genetic data suggest multiple transcription units, sequencing data showed that all 13 ORFs are closely linked and that there is no obvious inverted repeat at any of the intercistronic noncoding regions, suggesting that all of these genes may be transcribed in a single transcription unit. Thus, taking both the genetic complementation results and the sequence data together, it is likely that these cap genes are transcribed in a long operon with additional internal promoters. Because the more distal a gene is the less efficiently it is transcribed, the internal promoters would ensure that the downstream genes are produced in adequate amounts. We are currently employing Northern (RNA) blotting to study the gene transcription and Si mapping to determine the transcription start sites.
Recently, Hashimoto et al. (11) reported the nucleotide sequence of the ViaB region encoding Vi antigen in S. typhi and showed that three genes, vipA, vipB, and vipC, were involved in biosynthesis of the Vi polysaccharide. Vi polysaccharide is a homopolymer of N-acetylgalactosamino uronic acid (13) , which is one of the monomeric components of type MDHM, porcine heart malate dehydrogenase; MDHE, E. coli malate dehydrogenase; GALE, E. coli UDP-glucose epimerase. The alignment of the proteins LDHM, ADHE, G3P, VIPA, MDHM, MDHE, VIPB, and GALE is taken from Fig. 7 of Hashimoto et al. (11) .
VipA, across two distantly related bacterial genera is intriguing.
The VipA and VipB proteins have been shown to possess a putative NAD-binding domain by homology search (11) . This NAD-binding domain, which consists of about 30 amino acids with a three-dimensional structure of Pa,, is highly conserved among NAD-dependent dehydrogenases (49) . The deduced amino acid sequences of CapL and CapI also aligned well with this NAD-binding domain, suggesting that CapL and CapI are likely to have an NAD-binding domain (Fig. 7) . On the basis of the identification of an NAD-binding domain and sequence homology to VipA and VipB protein sequences, we propose that CapL and CapI may be the NAD-or NADP-dependent enzymes involved in the synthesis of N-acetylgalactosaminouronic acid.
